Company Monitoring Page for Merck

latest headlines for company on cafepharma

Merck opens Virginia plant to support UNICEF deal for HPV vaccines
Endpoints
Thu, 04/7/22 - 05:58 pm
Tags:
Merck, Virginia, drug manufacturing, UNICEF, vaccines, Gardasil 9, HPV
Merck looks to cardiovascular pipeline for $10B+ peak sales—and diversification from Keytruda
Fierce Biotech
Tue, 04/5/22 - 11:36 pm
Tags:
Merck, Keytruda, cardiovascular disease
Ukraine war, China's COVID lockdown and more could weigh on J&J's early-year performance—and it may not be alone: analysts
Fierce Pharma
Tue, 04/5/22 - 11:53 am
Tags:
JNJ, pandemic, Ukraine, COVID-19, Merck, Pfizer, Eli Lilly
How did Merck record an 11% tax rate last year? The Senate finance chairman would like to know
Fierce Pharma
Tue, 04/5/22 - 11:07 am
Tags:
Merck, Senate, taxes
New Studies Support Benefit of Merck's Molnupiravir
BioSpace
Mon, 04/4/22 - 11:13 pm
Tags:
Merck, Ridgeback Biotherapeutics, Lageviro, molnupiravir, clinical trials, ECCMID, COVID-19
Merck, nearing completion of $1B Gardasil manufacturing push, eyes 2023 to double production⁠—again
Fierce Pharma
Mon, 04/4/22 - 10:22 am
Tags:
Merck, vaccines, Gardasil, HPV, drug manufacturing
2 Drugmakers Set for Explosive Revenue This Decade
Motley Fool
Mon, 04/4/22 - 10:16 am
Tags:
Merck, Bristol Myers Squibb
Merck, amid pneumococcal vaccine race with Pfizer, suffers FDA delay for key pediatric use
Fierce Pharma
Fri, 04/1/22 - 10:45 am
Tags:
Merck, Pfizer, vaccines, pneumococcal disease, Vaxneuvance, FDA, pediatric
Workforce Cuts Abound at Zealand Pharma, Merck and Orchard
BioSpace
Thu, 03/31/22 - 10:43 am
Tags:
Zealand Pharma, Merck, Orchard Therapeutics, layoffs
Merck cuts 170 jobs at Acceleron right on heels of $11.5B buyout
Fierce Pharma
Wed, 03/30/22 - 11:05 am
Tags:
Merck, Acceleron, M&A, layoffs, Cambridge
Merck, Roche and J&J among pharma players weighing Russian operations amid humanitarian tightrope walk
Fierce Pharma
Tue, 03/29/22 - 11:43 pm
Tags:
Merck, JNJ, Roche, Russia, Ukraine
Bristol Myers Squibb, Merck hit setback in bid to expand Reblozyl's anemia nod
Fierce Pharma
Fri, 03/25/22 - 10:33 am
Tags:
Bristol Myers Squibb, Merck, Reblozyl, FDA, beta thalassemia
After Supreme Court win, Merck prevails against 500 Fosamax cases: report
Fierce Pharma
Thu, 03/24/22 - 08:34 pm
Tags:
Merck, legal, Fosamax, Supreme Court
Merck telegraphs closure of Pennsylvania antibiotics plant that employs 300
Fierce Pharma
Thu, 03/24/22 - 11:27 am
Tags:
Merck, drug manufacturing, antibotics, layoffs
FDA approves Merck’s anti-PD-1 therapy for endometrial carcinoma patients
Pharmaceutical Business Review
Tue, 03/22/22 - 10:41 am
Tags:
Merck, Keytruda, endometrial cancer, FDA
Merck fights back against Roche in adjuvant lung cancer therapy
Pharmaforum
Fri, 03/18/22 - 10:54 am
Tags:
Merck, Keytruda, non-small cell lung cancer, clinical trials, Roche, Tecentriq
Merck Announces Ups and Downs Involving Blockbuster Keytruda
BioSpace
Tue, 03/15/22 - 11:39 pm
Tags:
Merck, Keytruda
Merck antiviral used more than expected, data shows
Beckers Hospital Review
Mon, 03/14/22 - 11:35 pm
Tags:
Merck, Pfizer, antivirals, COVID-19, molnupiravir, Paxlovid
FDA clears AstraZeneca, Merck drug to treat some genetic breast cancers early
BioPharma Dive
Mon, 03/14/22 - 10:26 am
Tags:
AstraZeneca, Merck, Lynparza, genetic breast cancer, FDA
Death in Alpine's Keytruda combo trial triggers clinical hold, raises specter of earlier tragedy
Fierce Biotech
Mon, 03/7/22 - 11:01 pm
Tags:
Alpine Immune Sciences, davoceticept, Merck, Keytruda, clinical trials, patient deaths

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.